Indication
Esophageal adenocarcinoma
1 HCP commentary report on clinical trials in Esophageal adenocarcinoma. Each report covers what clinicians said in public about one trial, with the source behind every view.
| Trial | Indication | Phase | Statements | HCP sources | Size | Updated | Preview |
|---|---|---|---|---|---|---|---|
| MK-3475-975/KEYNOTE-975 NCT04210115 · Merck Sharp & Dohme LLC | Esophageal squamous cell carcinoma, Gastroesophageal junction cancer, Esophageal adenocarcinoma | Phase 3 | 180 | 16 | Standard | Oct 18, 2026 | Preview |